Pancreatic | Cases from the Community: Clinical Investigators Provide Perspectives on Actual Patients with Pancreatic Cancer

33:14
 
Share
 

Manage episode 229818577 series 1464352
By Dr Neil Love. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Faculty presentations from a CME symposium held at the 2019 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Andrew E Hendifar, Eileen M O’Reilly, Philip A Philip and Margaret A Tempero:

  • Available and Emerging Research Guiding the Treatment of Resectable or Borderline Resectable Pancreatic Adenocarcinoma (PAD) — Dr Tempero (0:00)
  • Patient- and Disease-Specific Factors Informing the Selection of Therapy for Locally Advanced, Unresectable PAD; Selection of First-Line Treatment for Metastatic Disease — Dr Philip (8:24)
  • Optimal Management of Metastatic Disease After Progression on First-Line Therapy — Dr O’Reilly (17:24)
  • Novel Agents and Strategies Under Investigation — Dr Hendifar (25:21)

Select publications

2185 episodes